Normal view MARC view ISBD view

Metabolic Dysfunction-Associated Steatotic Liver Disease [electronic resource] : Prevalence, research insights and the future directions / edited by Nahum Méndez-Sánchez, Xingshun Qi.

Contributor(s):

Material type:

TextPublisher: Singapore : Springer Nature Singapore : Imprint: Springer, 2024Edition: 1st ed. 2024Description: VIII, 170 p. 26 illus., 25 illus. in color. online resourceContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9789819795192

Subject(s):

Additional physical formats: Printed edition:: No title; Printed edition:: No title; Printed edition:: No titleLOC classification:

RC799-869

Online resources:

Resursa online

Contents:

-- Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD’s pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.

In: Springer Nature eBookSummary: This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.

Item type: List(s) this item appears in: Titluri cărți electronice Springer Nature 2025 (10631 titluri)

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.

There are no comments on this title.

to post a comment.